Trial
NCT03022565
Vorinostat in Patients With Class 2 High Risk Uveal Melanoma
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Miami
Collaborators
University of Miami Sylvester Comprehensive Cancer Center
Condition
Uveal Melanoma
Intervention
Vorinostat
Why stopped
Investigator Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-02-06